Different immunological requirements for protection against acute versus persistent Friend retrovirus infections

Virology. 2000 Jun 20;272(1):177-82. doi: 10.1006/viro.2000.0356.

Abstract

The propensity of retroviruses to rapidly establish persistent infections poses a formidable problem in vaccination strategies. In the current study, we use a live attenuated vaccine to study protection against acute and persistent Friend virus infections in mice. Adoptive transfers of immune CD8(+) T cells combined with passive immunizations with virus-neutralizing antibodies increased protection against acute disease compared with either treatment alone, but there was no protection against the establishment of persistent infection. In addition, the protection against acute disease elicited by the combination treatment was dependent on endogenous CD4(+) T cells as no protection was achieved in CD4(+) T-cell-depleted mice. Quantitative studies showed that doubling the numbers of immune lymphocytes used in adoptive transfer experiments increased protection against acute disease depending on the type of lymphocyte subset used in the transfer. CD8(+) T cells were the most potent subset for the transfer of such protection. However, even high numbers of immune CD8(+) T cells gave no protection against the establishment of persistent infections. The data indicate that strengthening the numbers of specific immune cell subsets may have a beneficial effect on protection against acute disease, but protection from establishment of persistence requires complex immune responses involving multiple lymphocyte subsets.

Publication types

  • Comparative Study

MeSH terms

  • Acute Disease
  • Adoptive Transfer
  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / immunology
  • Antibodies, Viral / administration & dosage
  • Antibodies, Viral / immunology
  • B-Lymphocytes / immunology
  • B-Lymphocytes / transplantation
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / transplantation
  • Chronic Disease
  • Female
  • Friend murine leukemia virus / immunology*
  • Friend murine leukemia virus / physiology
  • Mice
  • Neutralization Tests
  • Retroviridae Infections / immunology*
  • Retroviridae Infections / pathology
  • Retroviridae Infections / prevention & control*
  • Retroviridae Infections / virology
  • Splenomegaly / immunology
  • Splenomegaly / pathology
  • Splenomegaly / prevention & control
  • Splenomegaly / virology
  • T-Lymphocyte Subsets / immunology
  • Tumor Virus Infections / immunology
  • Tumor Virus Infections / pathology
  • Tumor Virus Infections / prevention & control
  • Tumor Virus Infections / virology
  • Vaccines, Attenuated / immunology
  • Viral Vaccines / immunology
  • Viremia / immunology
  • Viremia / prevention & control
  • Viremia / virology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Vaccines, Attenuated
  • Viral Vaccines